BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions

Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays a significant role in the survival and development of neurons, being involved in several diseases such as Alzheimer’s disease and major depression disorder. The association between BDNF and major depressive disorder is the subject...

Full description

Bibliographic Details
Main Authors: Ana Salomé Correia, Armando Cardoso, Nuno Vale
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/8/2081
_version_ 1797583473275305984
author Ana Salomé Correia
Armando Cardoso
Nuno Vale
author_facet Ana Salomé Correia
Armando Cardoso
Nuno Vale
author_sort Ana Salomé Correia
collection DOAJ
description Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays a significant role in the survival and development of neurons, being involved in several diseases such as Alzheimer’s disease and major depression disorder. The association between BDNF and major depressive disorder is the subject of extensive research. Indeed, numerous studies indicate that decreased levels of BDNF are linked to an increased occurrence of depressive symptoms, neuronal loss, and cortical atrophy. Moreover, it has been observed that antidepressive therapy can help restore BDNF levels. In this review, we will focus on the role of BDNF in major depression disorder serotonergic imbalance and associated stress conditions, particularly hypothalamic–pituitary–adrenal (HPA) axis dysregulation and oxidative stress. All of these features are highly connected to BDNF signaling pathways in the context of this disease, and exploring this topic will aim to advance our understanding of the disorder, improve diagnostic and treatment approaches, and potentially identify new therapeutic targets to alleviate the heavy burden of depression on society.
first_indexed 2024-03-10T23:39:23Z
format Article
id doaj.art-3e60af670513463b849237b14295e911
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T23:39:23Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-3e60af670513463b849237b14295e9112023-11-19T02:36:30ZengMDPI AGPharmaceutics1999-49232023-08-01158208110.3390/pharmaceutics15082081BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress ConditionsAna Salomé Correia0Armando Cardoso1Nuno Vale2OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Plácido da Costa, 4200-450 Porto, PortugalCINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, PortugalOncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Plácido da Costa, 4200-450 Porto, PortugalBrain-derived neurotrophic factor (BDNF) is a neurotrophin that plays a significant role in the survival and development of neurons, being involved in several diseases such as Alzheimer’s disease and major depression disorder. The association between BDNF and major depressive disorder is the subject of extensive research. Indeed, numerous studies indicate that decreased levels of BDNF are linked to an increased occurrence of depressive symptoms, neuronal loss, and cortical atrophy. Moreover, it has been observed that antidepressive therapy can help restore BDNF levels. In this review, we will focus on the role of BDNF in major depression disorder serotonergic imbalance and associated stress conditions, particularly hypothalamic–pituitary–adrenal (HPA) axis dysregulation and oxidative stress. All of these features are highly connected to BDNF signaling pathways in the context of this disease, and exploring this topic will aim to advance our understanding of the disorder, improve diagnostic and treatment approaches, and potentially identify new therapeutic targets to alleviate the heavy burden of depression on society.https://www.mdpi.com/1999-4923/15/8/2081major depressive disorderbrain-derived neurotrophic factorserotoninhypothalamic–pituitary–adrenal axisoxidative stress
spellingShingle Ana Salomé Correia
Armando Cardoso
Nuno Vale
BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
Pharmaceutics
major depressive disorder
brain-derived neurotrophic factor
serotonin
hypothalamic–pituitary–adrenal axis
oxidative stress
title BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
title_full BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
title_fullStr BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
title_full_unstemmed BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
title_short BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
title_sort bdnf unveiled exploring its role in major depression disorder serotonergic imbalance and associated stress conditions
topic major depressive disorder
brain-derived neurotrophic factor
serotonin
hypothalamic–pituitary–adrenal axis
oxidative stress
url https://www.mdpi.com/1999-4923/15/8/2081
work_keys_str_mv AT anasalomecorreia bdnfunveiledexploringitsroleinmajordepressiondisorderserotonergicimbalanceandassociatedstressconditions
AT armandocardoso bdnfunveiledexploringitsroleinmajordepressiondisorderserotonergicimbalanceandassociatedstressconditions
AT nunovale bdnfunveiledexploringitsroleinmajordepressiondisorderserotonergicimbalanceandassociatedstressconditions